ARKG vs FXI
ARK Genomic Revolution ETF vs iShares China Large-Cap ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
FXI—
iShares China Large-Cap ETF
Largest 50 Chinese companies.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | FXI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | iShares |
ARKG top holdings
Holdings data unavailable for ARKG.
FXI top holdings
Holdings data unavailable for FXI.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About FXI
FXI (iShares China Large-Cap ETF) is Largest 50 Chinese companies.